Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcomeric dysfunction in heart failure.

Nazha Hamdani1, Viola Kooij, Sabine van Dijk

  • 1Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, van der Boechorststraat 7, Amsterdam, The Netherlands.

Cardiovascular Research
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology, prevention, and management of coronary microvascular obstruction.

European heart journal·2026
Same author

Small Subset, Big Impact: Regulatory Function of γδ T Cells in Arteriogenesis.

Cells·2026
Same author

Genetic background is associated with distinct patterns of proarrhythmogenic remodeling leading to atrial fibrillation in pigs with ischemic heart failure.

Basic research in cardiology·2026
Same author

Clonal Hematopoiesis in Cardiovascular Risk: Focus on Inflammatory Mechanisms.

Journal of clinical medicine·2026
Same author

Repurposing PDE5-Inhibitors: Sildenafil Drives Arteriogenesis via Localized Regenerative Inflammation.

International journal of molecular sciences·2026
Same author

Sex and gender differences in coronary pathophysiology and ischaemic heart disease.

European heart journal·2026
Same journal

Interleukin-17A mediates cardiorenal injury in oxalate nephropathy.

Cardiovascular research·2026
Same journal

Air quality and health implications of exposure to ultrafine particle pollution.

Cardiovascular research·2026
Same journal

Long noncoding RNA CARDINAL cis-activates MYOCD expression by recruiting histone reader ZZZ3 in vascular smooth muscle cell phenotype alteration.

Cardiovascular research·2026
Same journal

Correction to: Myeloperoxidase aggravates thoracic aortic aneurysm formation in Marfan disease.

Cardiovascular research·2026
Same journal

YAP plays a critical role in myocardial recovery from myocarditis by suppressing IFN-γ signaling pathway.

Cardiovascular research·2026
Same journal

Metabolic crisis and TRPM4 activation cause QT prolongation in TANGO2 deficiency disorder.

Cardiovascular research·2026
See all related articles

Heart failure involves sarcomeric protein changes, primarily altered phosphorylation. Targeting these protein modifications may improve cardiac function in heart failure patients.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Sarcomeric dysfunction is a key factor in reduced cardiac pump function during heart failure.
  • Alterations in sarcomeric proteins include changes in isoform expression and post-translational modifications like proteolysis and phosphorylation.

Purpose of the Study:

  • To review the alterations in sarcomeric proteins in diseased myocardium.
  • To explore the role of protein phosphorylation in sarcomeric dysfunction in heart failure.
  • To discuss potential novel therapeutic strategies targeting sarcomeric protein phosphorylation.

Main Methods:

  • Review of recent studies in animal models of heart failure.
  • Analysis of human failing myocardium.
  • Focus on post-translational modifications of sarcomeric proteins.

Related Experiment Videos

Main Results:

  • Sarcomeric dysfunction, characterized by altered force development, Ca(2+) sensitivity, and passive stiffness, is linked to altered protein phosphorylation.
  • Neurohumoral-induced changes in the cardiomyocyte kinase-phosphatase balance are implicated in altered phosphorylation.
  • Evidence from both animal models and human studies converges on phosphorylation as a central mechanism.

Conclusions:

  • Altered protein phosphorylation is a primary driver of sarcomeric dysfunction in heart failure.
  • Novel therapies targeting specific phosphorylation sites or involved kinases/phosphatases show promise.
  • Improving sarcomeric protein phosphorylation balance could enhance cardiac function in heart failure.